| Biological Information | |
|---|---|
| Background Information: | N-terminal GST-tagged, recombinant, human MAP3K19, amino acids 941-end. MAP3K19 is an understudied kinase that is highly expressed in the lung and trachea. Its function is unknown, however, its activities have been linked to lung diseases, such as cancer and chronic obstructive pulmonary disease (COPD), as well as fibroblast development. |
| Target Class: | Kinase |
| Family: | STE (Ser/thr protein kinase) |
| Sub Family: | Serine/threonine kinase |
| Accession Number: | BC137277.1 |
| Target Name: | MAP3K19 |
| Target Aliases: | MAP3K19, RCK, YSK4, Mitogen-activated protein kinase kinase kinase 19 SPS1/STE20-related protein kinase Regulated in COPD protein kinase, Q56UN5 |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 12 months at -70°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Assay Information | |
| Assay Type: | Biochemical |
| Clinical Relevance | |
| Therapeutic Area: | Oncology/Immuno-Oncology |
MAP3K19, active
10 µg of active MAP3K19. N-terminal GST-tagged, recombinant, human MAP3K19, amino acids 941-end.
Datasheets
14-991_Datasheet
View Document